Infection and Immunity, November 1999, p. 5642-5650, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Biochemical Pharmacology,
Received 26 March 1999/Returned for modification 25 May
1999/Accepted 18 August 1999
The lungs are the remote organ most commonly affected in human
peritonitis. The major goals of this study were to define the dose- and
time-dependent relationship between graded septic peritonitis and
systemic and pulmonary inflammatory responses in mice. BALB/c mice were
treated with intraperitoneal polymicrobial inoculi and sacrificed at 3, 12, and 24 h. The treatment protocol resulted in distinct groups
of animals with respect to mortality rate, kinetics, and concentrations
of a broad spectrum of pro- and anti-inflammatory endogenous mediators,
intrapulmonary bacterial accumulation, and static lung compliance. In
sublethally infected mice, pulmonary bacterial proliferation was
controlled. Levels of monocyte chemoattractant protein-1 (MCP-1),
interleukin-10, interleukin-6, granulocyte colony-stimulating factor
(G-CSF), and tumor necrosis factor (TNF) in plasma were elevated 3 h after infection exclusively. At 3 h, MCP-1, gamma interferon,
and TNF were detected in extracts of pulmonary tissue or in
bronchoalveolar lavage (BAL) fluid. Static lung compliance
(Cst) was transiently decreased at 12 h. In contrast, in lethally infected mice pulmonary bacterial
proliferation was not contained. Concentrations of MCP-1, G-CSF, and
TNF in plasma were maximal at 24 h, as were pulmonary MCP-1
levels. Lung myeloperoxidase activity was increased at 3, 12, and
24 h. Cst was reduced after 3 h and
did not reach control values at 24 h. Pulmonary cyclooxygenase-2
mRNA and eicosanoids in BAL fluid and plasma were elevated at 3 and
24 h. This study shows that polymicrobial peritonitis in mice
leads to dose-dependent systemic and pulmonary inflammation accompanied
by a decrease in lung compliance.
*
Corresponding author. Mailing address: Research Center
Borstel, Division Pulmonary Pharmacology, Parkallee 22, 23845 Borstel, Germany. Phone: 49-4537-188478. Fax: 49-4537-188778. E-mail: SUhlig{at}fz-borstel.de.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|